Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01145066 · ClinicalTrials.gov registry record · Phase 2
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT01145066 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 80 participants.
The verdict
NCT01145066, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT fish oil
- DIETARY_SUPPLEMENT corn oil
- DRUG borage/echium oil combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01145066
The ClinicalTrials.gov registry entry for NCT01145066 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fish oil is the first listed.
NCT01145066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01145066 about?
NCT01145066 is a clinical study titled "Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects". This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.
What is the current status of trial NCT01145066?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2009-05. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01145066?
The interventions under investigation include: fish oil (DIETARY_SUPPLEMENT), corn oil (DIETARY_SUPPLEMENT), borage/echium oil combination (DRUG).
Who is sponsoring clinical trial NCT01145066?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.